Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy

Journal of Hypertension

Volumn 24, Issue 12, 2006, Pages 2445-2449

  Ponzetto, Antonio ^a   Cardaropoli, Simona ^b   Piccoli, Ettore ^b   Rolfo, Alessandro ^b   Gennero, Luisa ^a   Kanduc, Darja ^c   Todros, Tullia ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

CagA protein; Helicobacter pylori; Pre eclampsia

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; CAGA PROTEIN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFECTION RISK; ITALY; LOGISTIC REGRESSION ANALYSIS; PLACENTA; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE;

EID: 33750585353     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280109e8c     Document Type: Article

References (28)

1. Sibai BM. Hypertension in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics. Normal and problem pregnancies.. New York, NY: Churchill Livingstone; 1996. pp. 935-996.
2. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 births. Lancet 2001; 357:2002-2006.
3. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323:1213-1217.
4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
5. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
6. Davì G, Neri M, Falco A, Festi D, Taraborelli T, Ciabattoni G, et al. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol 2005; 25:246-251.
7. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347:1175-1186.
8. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003; 124:1846-1854.
9. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71:437-439.
10. Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, Hayashi J. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis 2005; 178:303-309.
11. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 2000; 5:S3-S9.
12. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. Int J Gynaecol Obstet 2002; 77:67-75.
13. Parazzini F, Cortinovis I, Bortolus R, Fedele L. Standard di peso alla nascita in Italia. Ann Ost Gin Med Perin 1991; CXII:203-246.
14. Ho SA, Hoyle JA, Lewis FA, Secker AD, Cross D, Mapstone NP, et al. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol 1991; 29:2543-2549.
15. Fusconi M, Vaira D, Menegatti M, Farinelli S, Figura N, Holton J, et al. Anti-CagA reactivity in Helicobacter pylori-negative subjects: a comparison of three different methods. Dig Dis Sci 1999; 44:1691-1695.
16. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter 2004; 9 (Suppl 1):1-6.
17. Graham DY, Osato MS, Olson CA, Zhang J, Figura N. Effect of H pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H pylori infection. Helicobacter 1998; 3:174-178.
18. Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, et al. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 1999; 31:290-294.
19. Xia HH, Lam SK, Chan AO, Lin MC, Kung HF, Ogura K, et al. Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells. World J Gastroenterol 2005; 11:1946-1950.
20. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70:427-451.
21. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40:102-111.
22. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynec Obstet 2001; 75:243-249.
23. Todros T, Bontempo S, Piccoli E, Ietta F, Romagnoli R, Biolcati M, et al. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 123:162-166.
24. Cardaropoli S, Silvagno F, Morra E, Pescarmona GP, Todros T. Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro. J Hypertens 2003; 21:2103-2110.
25. Trogstad LIS, Eskild A, Bruu AL, Jeansson S, Jenum PA. Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand 2001; 80:1036-1038.
26. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81:642-648.
27. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171:158-164.
28. Todros T, Verdiglione P, Oggè G, Paladini D, Vergani P, Cardaropoli S. Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection. Br J Clin Pharmacol 2006; 61:336-340.